Procalcitonin to Reduce Antibiotic Exposure during Acute Chest Syndrome in Adult Patients with Sickle-Cell Disease

Procalcitonin to Reduce Antibiotic Exposure during Acute Chest Syndrome in Adult Patients with Sickle-Cell Disease

Acute chest syndrome (ACS) is a major complication of sickle-cell disease. Bacterial infection is one cause of ACS, so current guidelines recommend the routine use of antibiotics. We performed a prospective before–after study in medical wards and an intensive-care unit (ICU). During the control phas...

Full description

Bibliographic Details
Main Authors: Keyvan Razazi, Ségolène Gendreau, Elise Cuquemelle, Mehdi Khellaf, Constance Guillaud, Bertrand Godeau, Giovanna Melica, Stéphane Moutereau, Camille Gomart, Slim Fourati, Nicolas De Prost, Guillaume Carteaux, Christian Brun-Buisson, Pablo Bartolucci, Anoosha Habibi, Armand Mekontso Dessap
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Journal of Clinical Medicine
Subjects:
sickle-cell disease
acute chest syndrome
procalcitonin
antibiotic
bacterial infection
Online Access:https://www.mdpi.com/2077-0383/9/11/3718

Similar Items

Similar Items